Table 1 Demographical characteristics and clinical data of the patients before and after PSM.
Variables | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
PONV group (n = 108) | No-PONV group (n = 284) | p Value | PONV group (n = 47) | No-PONV group (n = 47) | p Value | |
Demographics | ||||||
Age | 33 (25–45) | 60 (41–73) | < 0.01 | 38 (27–66) | 62 (41–74) | < 0.01 |
Gender (male%) | 44 (41%) | 193 (68%) | < 0.01 | 26 (55%) | 22 (47%) | 0.42 |
BMI (kg/m2) | 34 (25–44) | 24 (22–27) | < 0.01 | 27 (23–41) | 24 (22–27) | 0.20 |
Smoking (%) | 64 (60%) | 146 (51%) | 0.16 | 29 (62%) | 25 (53%) | 0.41 |
Hospital stay | 10 (9–13) | 11 (9–13) | 0.43 | 11 (9–13) | 11 (9–13) | 0.26 |
T2DM (%) | 41 (38%) | 120 (42%) | 0.44 | 19 (40%) | 24 (51%) | 0.31 |
GERD (%) | 47 (44%) | 60 (21%) | < 0.01 | 17 (36%) | 23 (49%) | 0.22 |
PONV HIS(%) | 92 (85%) | 223 (79%) | 0.12 | 39 (83%) | 41 (87%) | 0.57 |
Motion HIS(%) | 82 (76%) | 177 (62%) | < 0.01 | 35 (74%) | 30 (64%) | 0.27 |
Laboratory test | ||||||
NLR | 2.0 (1.6–2.9) | 1.7 (1.3–2.3) | < 0.01 | 1.8 (1.5–2.2) | 1.7 (1.3–2.3) | < 0.01 |
MLR | 1.9 (1.5–2.2) | 1.6 (1.3–2.2) | < 0.01 | 1.8 (1.3–2.0) | 1.6 (1.3–2.2) | 0.81 |
Operation | < 0.01 | 0.22 | ||||
LSG | 70 (65%) | 24 (8%) | 18 (38%) | 24 (51%) | ||
LDG | 30 (35%) | 260 (92%) | 29 (62%) | 23 (49%) | ||
Operation time | 167 (142–220) | 202 (165–240) | < 0.01 | 175 (150–210) | 202 (165–243) | 0.63 |
PCIA | 91 (84%) | 221 (78%) | 0.14 | 36 (77%) | 32 (68%) | 0.36 |
Opioid | 70 (65%) | 55 (19%) | < 0.01 | 21 (45%) | 16 (34%) | 0.29 |
Anisodamine | 44 (41%) | 100 (35%) | 0.31 | 20 (43%) | 15 (32%) | 0.30 |
Ondansetron | 57 (53%) | 13 (5%) | < 0.01 | 13 (28%) | 13 (28%) | 1.00 |